Revvity Inc
NYSE:RVTY
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
99.38
127.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Revvity Inc
Cash Equivalents
Revvity Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
R
|
Revvity Inc
NYSE:RVTY
|
Cash Equivalents
$1.2B
|
CAGR 3-Years
36%
|
CAGR 5-Years
26%
|
CAGR 10-Years
20%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash Equivalents
$4.6B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
30%
|
CAGR 10-Years
24%
|
|
|
Danaher Corp
NYSE:DHR
|
Cash Equivalents
$2.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-4%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash Equivalents
$71.6m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-6%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Cash Equivalents
$1.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash Equivalents
$1.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
13%
|
CAGR 10-Years
9%
|
|
Revvity Inc
Glance View
In the fast-evolving landscape of life sciences and diagnostics, Revvity Inc. stands as a vital player, driving innovation and delivering critical solutions to a diverse array of sectors. Established with a focus on precision, Revvity leverages its expertise in diagnostics and scientific services to address pressing global health challenges. The company operates by providing advanced analytical instruments, reagents, and software, enabling researchers and healthcare providers to conduct intricate analyses with unmatched reliability. Their offerings are crucial in areas such as prenatal and neonatal screening, as well as infectious disease detection, where accuracy is of paramount importance. Revenue generation at Revvity hinges on a hybrid model that includes product sales, service contracts, and licensing. By supplying state-of-the-art laboratory equipment, along with complementary services and software, the company creates a comprehensive ecosystem for research and diagnostic testing. The breadth of their portfolio appeals to a varied clientele, from hospital labs to large research institutions, ensuring a steady and diversified income stream. Furthermore, their commitment to research and development fosters long-term partnerships and secures their place at the forefront of scientific advancement, making Revvity a linchpin in both the healthcare and scientific communities.
See Also
What is Revvity Inc's Cash Equivalents?
Cash Equivalents
1.2B
USD
Based on the financial report for Sep 29, 2024, Revvity Inc's Cash Equivalents amounts to 1.2B USD.
What is Revvity Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
20%
Over the last year, the Cash Equivalents growth was 8%. The average annual Cash Equivalents growth rates for Revvity Inc have been 36% over the past three years , 26% over the past five years , and 20% over the past ten years .
You don't have any saved screeners yet
